| Name | Title | Contact Details |
|---|
EyePoint Pharmaceuticals is a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The Company`s pipeline leverages its proprietary Durasert® technology for sustained intraocular drug delivery including EYP-1901, a potential six-month intravitreal anti-VEGF treatment initially targeting wet age-related macular degeneration. Durasert`s proven intravitreal drug delivery platform has been safely administered to thousands of patients` eyes across four U.S. FDA-approved products, including YUTIQ® for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye, which is currently marketed by the Company. EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts.
IntraMed Educational Group is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
uLab | PDA is a Berkeley, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
HAA Preferred Partners is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
WellDyne is a Englewood, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.